April 1, 2024 10:48 AM EDT

FDA delays decision on Applied Therapeutics’ rare metabolic disease drug

The FDA has pushed back its decision date on Applied Therapeutics’ treatment for classic galactosemia to the end of November, the biotech

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA de­lays de­ci­sion on Ap­plied Ther­a­peu­tics’ rare meta­bol­ic dis­ease drug